{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:54:12Z","timestamp":1772560452815,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,3]]},"DOI":"10.7759\/cureus.104619","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:01:35Z","timestamp":1772557295000},"source":"Crossref","is-referenced-by-count":0,"title":["A Prospective Observational Study on Serum Lactate Dehydrogenase and Uric Acid Levels in Hypertensive Disorders of Pregnancy and Prediction of Fetomaternal Outcome"],"prefix":"10.7759","author":[{"given":"Kavya B","family":"Naganagoudar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhashchandra R","family":"Mudanur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajasri G","family":"Yaliwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreedevi","family":"Kori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laxmi","family":"Sangolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-025-07707-9","article-title":"Effect of hypertensive disorders of pregnancy (HDP) on maternal and perinatal birth outcomes in Eastern Ethiopia: a prospective cohort study","volume":"25","author":"Zerihun E","year":"2025","unstructured":"Zerihun E, Girma F, Amena N, et al.. Effect of hypertensive disorders of pregnancy (HDP) on maternal and perinatal birth outcomes in Eastern Ethiopia: a prospective cohort study. BMC Pregnancy Childbirth. 2025, 25:606. 10.1186\/s12884-025-07707-9","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.18231\/j.ijogr.57343.1763443473","article-title":"Outcomes of pregnancy complicated by hypertension: a study of maternal and fetal health","volume":"12","author":"Muthulingam D","year":"2025","unstructured":"Muthulingam D, Murugesan A, Sankar G. Outcomes of pregnancy complicated by hypertension: a study of maternal and fetal health. Indian J Obstet Gynecol Res. 2025, 12:619-26.","journal-title":"Indian J Obstet Gynecol Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2020.09.005","article-title":"Hypertensive disorders of pregnancy","volume":"39","author":"Khedagi AM","year":"2021","unstructured":"Khedagi AM, Bello NA. Hypertensive disorders of pregnancy. Cardiol Clin. 2021, 39:77-90. 10.1016\/j.ccl.2020.09.005","journal-title":"Cardiol Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003020","article-title":"ACOG practice bulletin No. 203: chronic hypertension in pregnancy","volume":"133","author":"American College of Obstetricians and Gynecologists","year":"2019","unstructured":"American College of Obstetricians and Gynecologists. ACOG practice bulletin No. 203: chronic hypertension in pregnancy. Obstet Gynecol. 2019, 133:e26-50. 10.1097\/AOG.0000000000003020","journal-title":"Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2020.08.011","article-title":"Hypertensive disorders of pregnancy","volume":"47","author":"Booker WA","year":"2020","unstructured":"Booker WA. Hypertensive disorders of pregnancy. Clin Perinatol. 2020, 47:817-33. 10.1016\/j.clp.2020.08.011","journal-title":"Clin Perinatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.34858","article-title":"Early identification of individuals at risk for hypertensive disorders of pregnancy","volume":"6","author":"Santos J","year":"2023","unstructured":"Santos J, Schenone MH, Garovic VD. Early identification of individuals at risk for hypertensive disorders of pregnancy. JAMA Netw Open. 2023, 6:e2334858. 10.1001\/jamanetworkopen.2023.34858","journal-title":"JAMA Netw Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5581570","article-title":"The role of oxidative stress in hypertensive disorders of pregnancy (preeclampsia, gestational hypertension) and metabolic disorder of pregnancy (gestational diabetes mellitus)","volume":"2021","author":"Phoswa WN","year":"2021","unstructured":"Phoswa WN, Khaliq OP. The role of oxidative stress in hypertensive disorders of pregnancy (preeclampsia, gestational hypertension) and metabolic disorder of pregnancy (gestational diabetes mellitus). Oxid Med Cell Longev. 2021, 2021:5581570. 10.1155\/2021\/5581570","journal-title":"Oxid Med Cell Longev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S309725","article-title":"Early prediction model of gestational hypertension by multi-biomarkers before 20 weeks gestation","volume":"14","author":"Zhou C","year":"2021","unstructured":"Zhou C, Song C, Huang X, et al.. Early prediction model of gestational hypertension by multi-biomarkers before 20 weeks gestation. Diabetes Metab Syndr Obes. 2021, 14:2441-51. 10.2147\/DMSO.S309725","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2174\/1573402114666181112141953","article-title":"Maternal serum uric acid as a predictor of severity of hypertensive disorders of pregnancy: a prospective cohort study","volume":"15","author":"Kumar N","year":"2019","unstructured":"Kumar N, Singh AK. Maternal serum uric acid as a predictor of severity of hypertensive disorders of pregnancy: a prospective cohort study. Curr Hypertens Rev. 2019, 15:154-60. 10.2174\/1573402114666181112141953","journal-title":"Curr Hypertens Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14080928","article-title":"Uric acid and preeclampsia: pathophysiological interactions and the emerging role of inflammasome activation","volume":"14","author":"Arias-S\u00e1nchez C","year":"2025","unstructured":"Arias-S\u00e1nchez C, P\u00e9rez-Olmos A, Reverte V, Hern\u00e1ndez I, Cuevas S, Llin\u00e1s MT. Uric acid and preeclampsia: pathophysiological interactions and the emerging role of inflammasome activation. Antioxidants. 2025, 14:928. 10.3390\/antiox14080928","journal-title":"Antioxidants"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2025.2496394","article-title":"Association between hyperuricemia and adverse perinatal outcomes among women with preeclampsia at a tertiary hospital in Southwestern Uganda: a prospective cohort study","volume":"38","author":"Omar Wehlie H","year":"2025","unstructured":"Omar Wehlie H, Fajardo Tornes Y, Businge J, et al.. Association between hyperuricemia and adverse perinatal outcomes among women with preeclampsia at a tertiary hospital in Southwestern Uganda: a prospective cohort study. J Matern Fetal Neonatal Med. 2025, 38:2496394. 10.1080\/14767058.2025.2496394","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1240848","article-title":"Diagnostic performance of lactate dehydrogenase as a potential biomarker in predicting preeclampsia and associated factors","volume":"11","author":"Teklemariam AB","year":"2024","unstructured":"Teklemariam AB, Abebe EC, Agidew MM, Ayenew AA, Mengistie MA, Baye ND, Muche ZT. Diagnostic performance of lactate dehydrogenase as a potential biomarker in predicting preeclampsia and associated factors. Front Med. 2024, 11:1240848. 10.3389\/fmed.2024.1240848","journal-title":"Front Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijogr.2024.108","article-title":"Lactate dehydrogenase as a biochemical marker for prediction of maternal and perinatal outcomes in hypertensive disorders in pregnancy","volume":"11","author":"Kumari N","year":"2024","unstructured":"Kumari N, Bala R, Pahwa S. Lactate dehydrogenase as a biochemical marker for prediction of maternal and perinatal outcomes in hypertensive disorders in pregnancy. Indian J Obstet Gynecol Res. 2024, 11:600-6. 10.18231\/j.ijogr.2024.108","journal-title":"Indian J Obstet Gynecol Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.6026\/973206300210116","article-title":"Lactate dehydrogenase (LDH) as an indicator of pre-eclampsia","volume":"21","author":"Raghuwanshi K","year":"2025","unstructured":"Raghuwanshi K, Kushram B, Dandotiya D, Petkar S, Tambade S, Gandhe M. Lactate dehydrogenase (LDH) as an indicator of pre-eclampsia. Bioinformation. 2025, 21:116-20. 10.6026\/973206300210116","journal-title":"Bioinformation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.86496","article-title":"Antepartum serum lactate dehydrogenase and adverse obstetric outcomes in preeclampsia: a systematic review of prognostic evidence from low- and middle-income countries","volume":"17","author":"Nguyen KD","year":"2025","unstructured":"Nguyen KD, Tn Khuc A, A Tran V, S Nguyen H, H Nguyen P, Th Nguyen A. Antepartum serum lactate dehydrogenase and adverse obstetric outcomes in preeclampsia: a systematic review of prognostic evidence from low- and middle-income countries. Cureus. 2025, 17:e86496. 10.7759\/cureus.86496","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/ijabmr.ijabmr_626_22","article-title":"A study on serum lactate dehydrogenase and uric acid in preeclampsia and eclampsia: can they predict adverse fetomaternal outcome?","volume":"13","author":"Moharana JJ","year":"2023","unstructured":"Moharana JJ, Mishra R, Nayak AK. A study on serum lactate dehydrogenase and uric acid in preeclampsia and eclampsia: can they predict adverse fetomaternal outcome?. Int J Appl Basic Med Res. 2023, 13:95-100. 10.4103\/ijabmr.ijabmr_626_22","journal-title":"Int J Appl Basic Med Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20240110","article-title":"Maternal serum lactate dehydrogenase level as a predictor of adverse pregnancy outcome in women with severe preeclampsia","volume":"13","author":"Awoyesuku PA","year":"2024","unstructured":"Awoyesuku PA, Ohaka C, Altraide BO, et al.. Maternal serum lactate dehydrogenase level as a predictor of adverse pregnancy outcome in women with severe preeclampsia. Int J Reprod Contracept Obstet Gynecol. 2024, 13:201-10. 10.18203\/2320-1770.ijrcog20240110","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20232293","article-title":"A study on lactate dehydrogenase levels in hypertensive disorders of pregnancy and its correlation with feto-maternal outcome","volume":"12","author":"Preet A","year":"2023","unstructured":"Preet A, Anand AR. A study on lactate dehydrogenase levels in hypertensive disorders of pregnancy and its correlation with feto-maternal outcome. Int J Reprod Contracept Obstet Gynecol. 2023, 12:2470-4. 10.18203\/2320-1770.ijrcog20232293","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18535\/jmscr\/v6i8.205","article-title":"A study of serum lactate dehydrogenase and uric acid level in preeclampsia in a tertiary health care centre in North East India","volume":"6","author":"Saha M","year":"2018","unstructured":"Saha M, Rohman SM, Das KK. A study of serum lactate dehydrogenase and uric acid level in preeclampsia in a tertiary health care centre in North East India. J Med Sci Clin Res. 2018, 6:1265-76. 10.18535\/jmscr\/v6i8.205","journal-title":"J Med Sci Clin Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20214842","article-title":"Maternal serum lactate dehydrogenase level and adverse pregnancy outcomes in women with hypertensive disorder of pregnancy at a tertiary care centre: a retrospective study","volume":"11","author":"Ajila D","year":"2021","unstructured":"Ajila D, Raja A, Ganiga P. Maternal serum lactate dehydrogenase level and adverse pregnancy outcomes in women with hypertensive disorder of pregnancy at a tertiary care centre: a retrospective study. Int J Reprod Contracept Obstet Gynecol. 2021, 11:44-9. 10.18203\/2320-1770.ijrcog20214842","journal-title":"Int J Reprod Contracept Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467743-a-prospective-observational-study-on-serum-lactate-dehydrogenase-and-uric-acid-levels-in-hypertensive-disorders-of-pregnancy-and-prediction-of-fetomaternal-outcome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:01:38Z","timestamp":1772557298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467743-a-prospective-observational-study-on-serum-lactate-dehydrogenase-and-uric-acid-levels-in-hypertensive-disorders-of-pregnancy-and-prediction-of-fetomaternal-outcome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.104619","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,3]]}}}